Age: 13.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Immunisation, Lymphadenopathy, Nausea, Pain
Clinical narrative: fatigue; Allergic reaction day after booster; soreness; headache; nausea; pain in chest; rapid heartbeat; swelling in face; lymph nodes in neck and jaw; tight throat; booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 13 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 14Jan2022 18:30 (Lot number: FJ5682) at the age of 13 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Possible diagnosis of Mast Cell Syndrome" (unspecified if ongoing), notes: Possible diagnosis of Mast Cell Syndrome; "Multiple allergies" (unspecified if ongoing), notes: Name of Drug as Reported: Multiple allergies as yet unsubstanciated by allergist.   , Reaction: Allergy. Concomitant medication(s) included: MIDOL [IBUPROFEN]. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0167), administration date: 15May2021, when the patient was 12 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0167), administration date: 05Jun2021, when the patient was 12 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 14Jan2022 18:30, outcome "unknown", described as "booster"; FATIGUE (non-serious) with onset 15Jan2022 07:00, outcome "not recovered", described as "fatigue"; HYPERSENSITIVITY (non-serious) with onset 15Jan2022 07:00, outcome "not recovered", described as "Allergic reaction day after booster"; PAIN (non-serious) with onset 15Jan2022 07:00, outcome "not recovered", described as "soreness"; HEADACHE (non-serious) with onset 15Jan2022 07:00, outcome "not recovered", described as "headache"; NAUSEA (non-serious) with onset 15Jan2022 07:00, outcome "not recovered", described as "nausea"; CHEST PAIN (non-serious) with onset 15Jan2022 07:00, outcome "not recovered", described as "pain in chest"; HEART RATE INCREASED (non-serious) with onset 15Jan2022 07:00, outcome "not recovered", described as "rapid heartbeat"; SWELLING FACE (non-serious) with onset 15Jan2022 07:00, outcome "not recovered", described as "swelling in face"; LYMPHADENOPATHY (non-serious) with onset 15Jan2022 07:00, outcome "not recovered", described as "lymph nodes in neck and jaw"; THROAT TIGHTNESS (non-serious) with onset 15Jan2022 07:00, outcome "not recovered", described as "tight throat". The events "fatigue", "allergic reaction day after booster", "soreness", "headache", "nausea", "pain in chest", "rapid heartbeat", "swelling in face", "lymph nodes in neck and jaw" and "tight throat" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of fatigue, hypersensitivity, pain, headache, nausea, chest pain, heart rate increased, swelling face, lymphadenopathy, throat tightness.  Additional Information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Treatment received for the adverse event were Anyphylaxis ER treatment, prednisone, cephalexin.Prior to vaccination, the patient was not diagnosed with COVID-19.   Follow-Up (20Jan2022): Follow-up attempts are completed. No further information is expected.